The UW Medicine-led research focuses on delivering a series of protein packets inside a shuttle vector to replace the defective DMD gene within the muscles. The added genetic code will then start producing dystrophin, the protein lacking in patients with muscular dystrophy.
![](https://sciencenewsnet.in/wp-content/uploads/2024/07/669813ef20b96_GenetherapyTasfaoutandChamberlain1.jpg)